Background
Ovarian cancer is the second most common cancer death in female genital system, and there will be approximately 21,750 estimated new cases and 13,940 estimated deaths in USA by the latest data from 2020 Cancer Statistics [
1]. Ovarian cancer is usually diagnosed at advanced stages due to the lack of typical clinical symptom and effective clinical diagnosis method at early stages [
2,
3]. It has been found that the development of ovarian cancer is closely related with the proliferation, invasion and migration of ovarian cancer cells [
4]. The metastasis of ovarian cancer usually leads to the recurrence and poor prognosis of ovarian cancer [
5]. Although standard surgery, radiotherapy and adjuvant chemotherapy have been applied to treat ovarian cancer patients [
6,
7], the survival rate is still not satisfactory [
8]. So, the metastasis and recurrence are needed to be controlled to improve the prognosis.
Previous studies have verified that many long non-coding RNAs (lncRNAs), such as lncRNA PTAR, lncRNA ABHD11-AS and lncRNA FLVCR1-AS1, promote the proliferation, invasion, migration, metastasis of ovarian cancer [
9,
10]. LINC00852 is a newly found lncRNA which is firstly discovered in lung adenocarcinoma [
11]. LINC00852 is overexpressed in lung adenocarcinoma spinal metastasis tissues and functions as an oncogene by promoting the proliferation, migration, and invasion of lung adenocarcinoma cells [
11]. In addition, a recent study has shown that LINC00852 expression is up-regulated in osteosarcoma and promotes the proliferation, migration, and invasion of osteosarcoma cancer cells [
12]. Moreover, LINC00852 can act as a ceRNA and competitively binding to miR-7-5p to exert its function in osteosarcoma [
12]. However, whether LINC00852 modulates the proliferation, migration, and invasion of ovarian cancer is not discovered.
MicroRNA-140-3p (miR-140-3p) is a cancer-related miRNA that acts as a tumor suppressor and suppresses the proliferation and migration in a variety of cancers, such as colorectal cancer, breast cancer, and non-small cell lung cancer [
13,
14]. A lot of studies have reported that miR-140-3p is decreased in cancer tissues and cancer cells, and miR-140-3p overexpression can inhibit the growth and tumorigenesis of cancers by directly inhibiting its target genes [
15,
16]. Importantly, Gregory et al. have identified that miR-140-3p expression is down-regulated in ovarian cancer tissue by miRNA microarray analysis [
17]. However, the role of miR-140-3p in the regulation of the proliferation and migration of ovarian cancer is not understood.
Angiotensin II Receptor Type 1 (AGTR1) is a receptor for angiotensin II and mediates the major cardiovascular effects of angiotensin II which acts as an effective vasopressor hormone and a major regulator of aldosterone secretion [
18,
19]. According to the previous reports, AGTR1 exerts important functions in promoting the proliferation, invasion, migration and angiogenesis of cancer cells, such as glioma cells, breast cancer, cells and pancreatic cancer [
20,
21]. On the contrary, AGTR1 antagonists can suppress the angiogenesis, migration and invasion of lung adenocarcinoma [
22,
23]. Besides, AGTR1 has been found to promote the proliferation, migration and metastasis of ovarian cancer by triggering ERK1/2 and AKT signaling pathways, and AGTR1 overexpression predicts a poor prognosis of ovarian cancer [
24].
In the present study, we investigated the role of LINC00852/miR-140-3p/AGTR1 pathway in ovarian cancer, and found LINC00852 acted as a ceRNA of miR-140-3p to repress miR-140-3p expression thereby promoting AGTR1 expression to promote the growth and invasion of ovarian cancer in vitro and in vivo.
Methods
Sample collection
Eighty-five ovarian cancer tissue and adjacent normal tissue samples were collected from ovarian cancer patients who underwent surgical resection at Cancer Hospital of China Medical University. Written informed consent was obtained from all patients. Tumor samples were confirmed by two pathologists independently and immediately frozen in liquid nitrogen. No patients received preoperative chemotherapy or radiotherapy. This study was approved by the Ethics Committee of Cancer Hospital of China Medical University.
Cell culture and transfection
Normal human ovarian epithelial cell line IOSE80 and human ovarian cancer cell lines (A2780, SKOV-3, OV-90, and CAOV3) were used in this study. The cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM; Gibco, CA, USA) or Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco, CA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, CA, USA), 2% sodium pyruvate (Gibco, CA, USA), 1% penicillin-streptomycin (Gibco, CA, USA) in an incubator containing 5% CO2 at 37 °C.
The vectors used for LINC00852 knockdown (sh, short hairpin)-LINC00852-1, sh-LINC00852-2, and sh-LINC00852-3), LINC00852 negative control (sh-NC), LINC00852 overexpression (oe-LINC00852 vecter was constructed by LINC00852 inserting into pcDNA3.1) and its negative control (oe-NC), miR-140-3p overexpression (miR-140-3p mimic) and its negative control (mimic NC), miR-140-3p knockdown (miR-140-3p inhibitor) and its negative control (inhibitor NC), and AGTR1 knockdown (sh-AGTR1) were synthesized by RiboBio (Guangdong, China). Transfection experiments were conducted using Lipofectamine 2000 (Invitrogen, CA, USA) according to the manufacturer’s instructions.
CCK-8 assay
SKOV-3 and OV-90 cells with different transfections were seeded into 96-well plates at a concentration of 1.5 × 104/mL. Forty-eight hours later, SKOV-3 and OV-90 cells were added with CCK-8 solution (10 μL; Sigma-Aldrich, MI, USA) and incubated for 2 h. The absorbance was measured at 450 nm by a microplate reader (Bio-Rad, CA, USA) at 24 h, 48 h and 72 h.
SKOV-3 and OV-90 cells with different transfections were seeded into 6-well plates at a concentration of 200 cells per well and cultured for 14 days. Then, SKOV-3 and OV-90 cell colonies were fixed with 80% methanol for 30 min and stained with 0.25% crystal violet at room temperature for 30 min.
Hoechst 33342 staining
The apoptosis of SKOV-3 and OV-90 cells with different transfections was confirmed by Hoechst 33342 staining according to previous report [
25]. SKOV-3 and OV-90 cells were seeded in culture dish, added with 10 μL Hoechst 33342 solution (Beyotime Biotechnology, Nantong, China), and cultured for 10 min at 25 °C. A fluorescence microscopy (Olympus, Tokyo, Japan) was used to observe the changes in morphology of SKOV-3 and OV-90 cells (chromatin condensation, fragmentation and cell shrinkage). The apoptotic cancer cells were counted from 400 cells in 12 fields/well, and apoptosis rate (%) = apoptotic cancer cells/total cancer cells× 100.
Transwell assay
Mitomycin C (10 g/ml) was added to the cell culture medium to inhibit cell replication, which ruled out the changes in intercellular space caused by cell proliferation or apoptosis [
26]. SKOV-3 and OV-90 cells (2 × 10
5 cells/mL) were added to the upper chambers of Transwell (8-μm-diameter pore membrane; Corning, NY, USA) coated with Matrigel. SKOV-3 and OV-90 cells were allowed to invade for 24 h, and cotton swabs were used to scrub cancer cells that did not penetrated the filters. Then, chambers were fixed with 4% paraformaldehyde (Beyotime Biotechnology, Nantong, China) for 2 min, stained with 0.3% crystal violet (Beyotime Biotechnology, Nantong, China) for 2 min and observed under a light microscope (Olympus, Tokyo, Japan).
qRT-PCR
Total RNAs were extracted from tumor tissues and ovarian cancer cells (SKOV-3 and OV-90 cells) using Trizol Reagent (Invitrogen, CA, USA). Complementary DNA (cDNA) was synthesized using High-Capacity RNA-to-cDNA Kit (Applied Biosystems, CA, USA) according to the manufacturer’s instruction. qRT-PCR reactions were conducted on an ABI StepOne Real-time PCR System (Applied Biosystems, CA, USA) using PowerUp SYBR Green Master Mix with the primers as the following: LINC00852 forward, 5′-CGTTGCCTACAGTCAAGTCAGT-3′, reverse, 5′-GCCATGGTTCCCTTACTGATAC-3′; miR-140-3p forward, 5′-ACACTCCAGCTGGGAGGCGGGGCGCCGCGGGA-3′, reverse, 5′-CTCAACTGGTGTCGTGGA-3′; AGTR1 forward, 5′-CCTCAGATAATGTAAGCTCATCCAC-3′, reverse, 5′-GCTGCAGAGGAATGTTCTCTT-3′; U6 forward, 5′-CTCGCTTCGGCAGCACA-3′, reverse, 5′-AACGCTTCACGAATTTGCGT-3′; GAPDH forward, 5′-TGTTCGTCATGGGTGTGAAC-3′, reverse, 5′-ATGGCATGGACTGTGGTCAT-3′. Relative gene expressions of LINC00852, miR-140-3p and AGTR1 were calculated using the2-ΔΔCt method and normalized by GAPDH or U6.
Western blotting
Proteins were extracted from tumor tissues and ovarian cancer cells (SKOV-3 and OV-90 cells) using RIPA lysis and extraction buffer (ThermoFisher Scientific, CA, USA). The concentration of proteins was measured using BCA protein assay kit (ThermoFisher Scientific, CA, USA). Proteins were separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene fluoride membranes (PVDF; Invitrogen, CA, USA). The blots were blocked with 5% skimmed milk, and incubated with primary antibodies overnight at 4 °C: MMP-2 (1:1000; Abcam, Cambridge, UK), MMP-9 (1:5000; Abcam, Cambridge, UK), Ki67 (1:1000; Abcam, Cambridge, UK), PCNA (1:5000; Abcam, Cambridge, UK), MEK (1:1000; Cell Signaling Technology, MA, USA), p-MEK (1:1000; Cell Signaling Technology, MA, USA), ERK1/2 (1:1000; Abcam, Cambridge, U), p-ERK1/2 (1:1000; Cell Signaling Technology, MA, USA), STAT3 (1:1000; Cell Signaling Technology, MA, USA), p-STAT3 (1:2000; Cell Signaling Technology, MA, USA), GAPDH (1:1000; Cell Signaling Technology, MA, USA). The blots were then incubated with goat anti-rabbit or anti-mouse secondary antibody (Cell Signaling Technologies, MA, USA), visualized by an enhanced chemiluminescence kit (ThermoFisher Scientific, CA, USA) and normalized to GAPDH expression. The membranes were firstly cut, and then stained with antibodies. Each complete membrane has GAPDH loading control. The bands were photographed with a ChemiDoc™XRS Imaging System (Bio-Rad, CA, USA) and quantified by Quantity One software (Bio-Rad, CA, USA).
Detection of gelatin zymography by mono-dimensional gel electrophoresis
The enzymatic activity of MMP-2 and MMP-9 in SKOV3 and OV-90 cells was conducted with gelatine zymography. Proteins (20 μg) extracted from ovarian cancer cells (SKOV-3 and OV-90 cells) were used for each zymographic assay. Under non-reducing condition, mono-dimensional gelatine zymography was conducted on SDS-PAGE (7.5%) copolymerized with gelatine (0.1%). After electrophoresis, SDS was removed from the gels and zymograms were developed for 18 h at 37 °C. Gels were then stained with Coomassie Brilliant Blue for 30 min at 25 °C and visualized after destaining in methanol/acetic acid/H2O.
Flourescence in situ hybridization (FISH) assay
FISH was conducted according to previous report [
27]. Digoxin (Sigma-Aldrich, MI, USA)-labeled LINC00852 complementary DNA probe was synthesized in vitro. SKOV-3 cells were grown on the slides. After washed with phosphate buffer solution (PBS) for three times, SKOV-3 cells grown on the slides were fixed with 4% paraformaldehyde (Beyotime Biotechnology, Nantong, China). Then, the slides were treated with protease reagent (Invitrogen, CA, USA) and hybridized with digoxin-labeled LINC00852 probe for 12 h at 40 °C. Images were observed by a confocal microscope (Olympus, Tokyo, Japan) and the magnification of images was 400 × objective.
Dual luciferase reporter gene assay
The luciferase reporter gene assay was conducted according to previous report [
28]. The sequences of miR-140-3p or AGTR1 3′-UTR was sub-cloned into pGL3 luciferase reporter vectors (Promega, WI, USA). SKOV-3 cells were seeded into 48-well plates at a concentration of 3 × 10
4 cells/well, and transfected with wide type miR-140-3p vector (pGL3-miR-140-3p-wt) or mutant miR-140-3p vector (pGL3-miR-140-3p-mut), wide type 3′-UTR of AGTR1 vector (pGL3-AGTR1-wt), mutant 3′-UTR of AGTR1 vector (pGL3-AGTR1-mut) using Lipofectamine 2000 reagent (Invitrogen, CA, USA). Forty-eight hours later, luciferase activity was detected by dual luciferase reporter assay system (Progema, WI, USA).
RNA immunoprecipitation (RIP) assay
RIP assay was conducted as previously described [
29]. SKOV-3 cells (2 × 10
7) were collected to perform RIP assay using an AGO2 antibody (Millipore, MA, USA). AGO2 antibody (5 μg) for each RIP was used in RIP assay, and normal rabbit IgG was used as negative control. The co-precipitated RNAs were isolated and detected by qRT-PCR.
RNA pull-down assay
SKOV-3 cells were transfected with biotin-labeled wild-type miR-140-3p probe (bio-miR-140-3p-wt), biotin-labeled mutant miR-140-3p probe (bio-miR-140-3p-mut) or negative control probe (bio-probe NC). After 48 h, SKOV-3 cells were collected and lysed using RIPA lysis and extraction buffer (ThermoFisher Scientific, CA, USA). Then, cell lysates were incubated with Streptavidin magnetic beads (Pierce, CA, USA) for 12 h at 4 °C. After elution of Streptavidin magnetic beads, the bound RNAs were detected using qRT-PCR.
Xenograft mouse model
Ovarian cancer xenograft mouse model was established by subcutaneously injecting BALB/c nude mice (4–5 weeks, weight 20 ± 0.5 g, female) with 1 × 107 SKOV-3 cells transfected with sh-LINC00852 or sh-NC (sh-LINC00852 and sh-NC groups), with five mice in each group. For control group, BALB/c nude mice were injected with SKOV-3 cells without transfection. BALB/c nude mice were obtained from Charles River (Beijing, China), and kept in individual cages with standard chow and ad libitum access to drinking water under a sterile condition. Tumor volumes were assessed by measuring the length and width of the tumor with calipers (tumor volume [mm3] = 0.5 × length×width2). The length and width were detected between 09.00 am to 10.00 am and testing order was randomized daily by two investigators who are unaware of grouping. Six weeks later, all mice were euthanized by an overdose of 100 mg/kg sodium pentobarbital through intravenous injection. And the tumors were excised, photographed and weighed. The animal experiment was approved by the Animal Care and Use Committee of Cancer Hospital of China Medical University.
Immunohistochemistry (IHC) analysis
Tumor tissue sections were de-paraffinized and rehydrated using descending concentrations of ethanol. Then, tumor tissue sections were added with 3% H2O2 for 30 min and blocked with 1% FBS for 1 h. After that, tumor tissue sections were incubated with anti-MMP-2 (1:100; Abcam, Cambridge, UK), anti-MMP-9 (1:1000; Abcam, Cambridge, UK), anti-Ki67 (1:1000; Abcam, Cambridge, UK) and anti-PCNA (1:200; Abcam, Cambridge, UK) overnight at 4 °C. Then, the sections were washed with PBS and incubated with secondary antibodies (1:500; Abcam, Cambridge, UK) for 1 h at room temperature. Finally, tumor tissue sections were stained with 3,3′-diaminobenzidine (DAB) staining solution and observed by a fluorescence microscope (Nikon, Tokyo, Japan).
SKOV-3 cells (1 × 106/0.2 ml) transfected with sh-LINC00852-1 or sh-NC were injected into the tail veins of 15 BALB/c nude mice (4–5 weeks, weight 20 ± 0.5 g, female). BALB/c nude mice were obtained from Charles River (Beijing, China), and kept in individual cages with standard chow and ad libitum access to drinking water under a sterile condition. For control group, BALB/c nude mice were injected with SKOV-3 cells without transfection. There were five mice in each group. The mice were sacrificed 4 weeks after the inoculation and lungs were removed. Then, metastatic nodules were counted macroscopically.
Statistical analysis
GraphPad Prism 5.0 was used for data analysis. Data were expressed as mean ± standard deviation (SD). Comparisons for two groups were analyzed by Student’s t-test. Comparisons for multiple groups were analyzed by one-way analysis of variance ANOVA followed by Bonferroni post hoc test. P value less than 0.05 was considered statistically significant.
Discussion
LINC00852, also known as nasopharyngeal carcinoma related gene NAG73, C3orf42, ghrelin opposite strand/antisense RNA (GHRLOS), and GHRL-AS2, can be highly expressed in cancer tissues and cancer cells, such as gastric cancer and thyroid cancer [
34,
35]. The highly expressed lncRNAs usually act as oncogenes to promote the progression of cancer, and lowly expressed lncRNAs usually act as tumor suppressers to suppress the progression of cancer [
36,
37]. A report by Seim et al. has illustrated that GHRLOS (LINC00852) expression was highly expressed in human cerebellum, foetal brain, whole brain, thymus, thyroid, testis, uterus and ovary [
35]. However, whether LINC00852 acts as oncogene or tumor suppressing gene in ovarian cancer is not clear. So, it is meaningful for identifying the role of LINC00852 in the regulation of ovarian cancer progression. In this study, we found that LINC00852 was highly expressed in ovarian cancer tissues and ovarian cancer cells. Therefore, we first identified that LINC00852 was up-regulated in ovarian cancer, which might play vital roles in the progression of ovarian cancer.
The dysregulation of lncRNAs is involved in modulating the proliferation, migration, invasion and metastasis of cancers [
38]. As a new modulatory RNA molecule, GHRLOS (LINC00852) was up-regulated in gastric cancer tissues, and high expression of GHRLOS predicted poor overall survival in patients of gastric cancer [
34]. LINC00852 was up-regulated in lung adenocarcinoma spinal metastases and lung adenocarcinoma cells, and LINC00852 overexpression promoted the proliferation and inhibited the apoptosis of lung adenocarcinoma cells in vitro [
11]. GHRLOS (LINC00852) was lowly expressed in colorectal cancer tissues, and decreased expression of GHRLOS was correlated with distant metastasis, lymph node metastasis and poor histological tumor grade [
39]. In addition, high expression of GHRLOS promoted the proliferation and migration of breast cancer cells in vitro, and GHRLOS overexpression facilitated the orthotopic xenograft growth in vivo [
40]. These studies indicate LINC00852 might exert important functions in regulating the progression of a variety of cancers. In this study, loss-of-function assays illustrated that LINC00852 knockdown decreased cell viability, inhibited the colony formation and invasion of ovarian cancer cells, and promoted the apoptosis of ovarian cancer cells in vitro. These results first illustrated that LINC00852 functioned as an oncogene in ovarian cancer for promoting the proliferation and invasion of ovarian cancer cells.
Studies have identified that the expression of miR-140 can be reduced by lncRNAs in several cancer cells [
41,
42]. By competitively binding with miR-140, a variety of lncRNAs, such as lncRNA XIST, lncRNA MALAT1 and lncRNA H19, can promote cancer progression via facilitating the proliferation, migration and invasion of cancer cells in vitro and metastasis in vivo [
42]. For example, lncRNA PGM5-AS1 directly bound with miR-140 in osteosarcoma cells to modulate downstream FBN1 pathway, thereby affecting invasion, migration and tumorigenesis of osteosarcoma [
43]. LncRNA SNHG20 directly bound with miR-140 in laryngeal squamous cell carcinoma cells, and SNHG20 knockdown decreased the proliferation and suppressed the malignant progression of laryngeal squamous cell carcinoma [
44]. In this study, we confirmed the subcellular localization of LINC00852 in the cytoplasm. Dual luciferase reporter gene assay together with RIP assay and RNA pull down assay showed that miR-140-3p was a downstream molecule of LINC00852, and LINC00852 acted as a sponge for miR-140-3p in ovarian cancer cells. We further found that miR-140-3p was down-regulated in ovarian cancer tissues. LINC00852 significantly reduced the cell viability, inhibited the colony formation and invasion of ovarian cancer cells, and promoted the apoptosis of ovarian cancer cells in vitro by sponging miR-140-3p. To the best of our knowledge, this study firstly confirmed that the expression and biological functions of LINC00852 in ovarian cancer, and identified that LINC00852 knockdown increased miR-140-3p expression to suppress the proliferation and invasion of ovarian cancer cells.
A lot of target genes of miR-140-3p, including RRM2, PD-L1, MAPK and BRD9, can be remarkably suppressed by miR-140-3p in cancer cells through binding to the 3′-untranslated regions (3′ UTRs) [
13,
45]. It has been reported that AGTR1 expression is related with the growth, metastasis and poor prognosis in breast cancer, colorectal cancer and gastric cancer [
46]. Moreover, AGTR1 has been verified to promote the colony formation, migration and metastasis of ovarian cancer cells [
24]. MEK/ERK/STAT3 pathway has been found to be involved in regulating the proliferation, invasion and migration of ovarian cancer cells and hepatocellular carcinoma cells [
47]. In addition, AGTR1 has been identified to be the upstream molecule of MEK/ERK/STAT3 pathway in regulating the growth and metastasis of prostate cancer [
48]. In this study, we found that AGTR1 was the target gene modulated by miR-140-3p. The introduction of AGTR1 knockdown reversed the promotion effect of miR-140-3p inhibitor on the activation of MEK/ERK/STAT3 pathway in ovarian cancer cells, indicating the loss of AGTR1 expression can result in the inhibition of ovarian cancer progression.
The metastasis of ovarian cancer is a main factor that contributes to the recurrence and poor prognosis of ovarian cancer [
49]. More and more in vivo experiments have verified that lncRNAs could affect the metastasis of tumors to regulate the progression of ovarian cancer [
50,
51]. In this study, we found that the loss of LINC00852 significantly reduced tumor volume and tumor weight in a SKOV-3 xenograft mouse model. Besides, the loss of LINC00852 significantly increased miR-140-3p expression, reduced AGTR1 expression and inhibited the activation of MEK/ERK/STAT3 pathway in tumor tissues from SKOV-3 xenograft mice. Moreover, IHC staining showed the invasion marker MMP-2, MMP-9, Ki67 and PCNA were down-regulated by the loss of LINC00852, suggesting LINC00852 could promote the invasion of ovarian cancer in vivo. We will focus on the effects of high/low LINC00852 and miR-140-3p expressions on the prognosis of ovarian cancer patients in further researches.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.